359 related articles for article (PubMed ID: 20406971)
1. Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis.
Bassères DS; Ebbs A; Levantini E; Baldwin AS
Cancer Res; 2010 May; 70(9):3537-46. PubMed ID: 20406971
[TBL] [Abstract][Full Text] [Related]
2. A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity.
Jeong SJ; Pise-Masison CA; Radonovich MF; Park HU; Brady JN
J Biol Chem; 2005 Mar; 280(11):10326-32. PubMed ID: 15611068
[TBL] [Abstract][Full Text] [Related]
3. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
[TBL] [Abstract][Full Text] [Related]
4. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
[TBL] [Abstract][Full Text] [Related]
5. Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogen-activated protein kinase p38.
Madrid LV; Mayo MW; Reuther JY; Baldwin AS
J Biol Chem; 2001 Jun; 276(22):18934-40. PubMed ID: 11259436
[TBL] [Abstract][Full Text] [Related]
6. Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma.
Meylan E; Dooley AL; Feldser DM; Shen L; Turk E; Ouyang C; Jacks T
Nature; 2009 Nov; 462(7269):104-7. PubMed ID: 19847165
[TBL] [Abstract][Full Text] [Related]
7. Oncogenic Ras mutant causes the hyperactivation of NF-κB via acceleration of its transcriptional activation.
Tago K; Funakoshi-Tago M; Ohta S; Kawata H; Saitoh H; Horie H; Aoki-Ohmura C; Yamauchi J; Tanaka A; Matsugi J; Yanagisawa K
Mol Oncol; 2019 Nov; 13(11):2493-2510. PubMed ID: 31580526
[TBL] [Abstract][Full Text] [Related]
8. p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation.
Kawauchi K; Araki K; Tobiume K; Tanaka N
Nat Cell Biol; 2008 May; 10(5):611-8. PubMed ID: 18391940
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation.
Finco TS; Westwick JK; Norris JL; Beg AA; Der CJ; Baldwin AS
J Biol Chem; 1997 Sep; 272(39):24113-6. PubMed ID: 9305854
[TBL] [Abstract][Full Text] [Related]
10. The nuclear factor kappaB subunits RelA/p65 and c-Rel potentiate but are not required for Ras-induced cellular transformation.
Hanson JL; Hawke NA; Kashatus D; Baldwin AS
Cancer Res; 2004 Oct; 64(20):7248-55. PubMed ID: 15492243
[TBL] [Abstract][Full Text] [Related]
11. IKKβ targeting reduces KRAS-induced lung cancer angiogenesis in vitro and in vivo: A potential anti-angiogenic therapeutic target.
Carneiro-Lobo TC; Scalabrini LC; Magalhães LDS; Cardeal LB; Rodrigues FS; Dos Santos EO; Baldwin AS; Levantini E; Giordano RJ; Bassères DS
Lung Cancer; 2019 Apr; 130():169-178. PubMed ID: 30885340
[TBL] [Abstract][Full Text] [Related]
12. NF-kappaB-dependent transcriptional activation in lung carcinoma cells by farnesol involves p65/RelA(Ser276) phosphorylation via the MEK-MSK1 signaling pathway.
Joo JH; Jetten AM
J Biol Chem; 2008 Jun; 283(24):16391-9. PubMed ID: 18424438
[TBL] [Abstract][Full Text] [Related]
13. Selective killing of lung cancer cells by miRNA-506 molecule through inhibiting NF-κB p65 to evoke reactive oxygen species generation and p53 activation.
Yin M; Ren X; Zhang X; Luo Y; Wang G; Huang K; Feng S; Bao X; Huang K; He X; Liang P; Wang Z; Tang H; He J; Zhang B
Oncogene; 2015 Feb; 34(6):691-703. PubMed ID: 24469051
[TBL] [Abstract][Full Text] [Related]
14. Conditional ablation of Ikkb inhibits melanoma tumor development in mice.
Yang J; Splittgerber R; Yull FE; Kantrow S; Ayers GD; Karin M; Richmond A
J Clin Invest; 2010 Jul; 120(7):2563-74. PubMed ID: 20530876
[TBL] [Abstract][Full Text] [Related]
15. HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity.
Jeong SJ; Radonovich M; Brady JN; Pise-Masison CA
Blood; 2004 Sep; 104(5):1490-7. PubMed ID: 15155458
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation.
Ludwig L; Kessler H; Wagner M; Hoang-Vu C; Dralle H; Adler G; Böhm BO; Schmid RM
Cancer Res; 2001 Jun; 61(11):4526-35. PubMed ID: 11389085
[TBL] [Abstract][Full Text] [Related]
17. Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras.
Mayo MW; Wang CY; Cogswell PC; Rogers-Graham KS; Lowe SW; Der CJ; Baldwin AS
Science; 1997 Dec; 278(5344):1812-5. PubMed ID: 9388187
[TBL] [Abstract][Full Text] [Related]
18. IKK is a therapeutic target in KRAS-Induced lung cancer with disrupted p53 activity.
Bassères DS; Ebbs A; Cogswell PC; Baldwin AS
Genes Cancer; 2014 Apr; 5(1-2):41-55. PubMed ID: 24955217
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of NF-kappaB activity and NF-kappaB p65 subunit expression by ras and polyoma middle T oncogenes in human colonic Caco-2 cells.
Cadoret A; Bertrand F; Baron-Delage S; Lévy P; Courtois G; Gespach C; Capeau J; Cherqui G
Oncogene; 1997 Apr; 14(13):1589-600. PubMed ID: 9129150
[TBL] [Abstract][Full Text] [Related]
20. N-tosyl-L-phenylalanine chloromethyl ketone inhibits NF-kappaB activation by blocking specific cysteine residues of IkappaB kinase beta and p65/RelA.
Ha KH; Byun MS; Choi J; Jeong J; Lee KJ; Jue DM
Biochemistry; 2009 Aug; 48(30):7271-8. PubMed ID: 19591457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
